Ownership history in Stonepine Capital Management, LLC · 6 quarters on record
This page tracks every 13F SEC filing in which Stonepine Capital Management, LLC reported a position in DAY ONE BIOPHARMACEUTICALS I (DAWN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 200,000 | -447,382 | -69.1% | 1.36% | $1.9M | $9.32 |
| 2025 Q3 | ADDED | 647,382 | +197,382 | +43.9% | 3.71% | $4.56B | $7.05 |
| 2025 Q2 | ADDED | 450,000 | +101,180 | +29.0% | 2.87% | $2.9M | $6.50 |
| 2025 Q1 | ADDED | 348,820 | +113,820 | +48.4% | 2.69% | $2.77B | $7.93 |
| 2024 Q4 | ADDED | 235,000 | +29,325 | +14.3% | 2.40% | $3.0M | $12.67 |
| 2024 Q3 | INITIATED | 205,675 | — | — | 1.81% | $2.9M | $13.93 |
As of 2025 Q4 — sorted by position size